4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-138944
Chief Legal Officer sold 3,738 shares at $20.35 ($76,068)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali-Jackson Kamil Chief Legal Officer | 2016-08-26 | Sale | −3,738 | $20.35 | $76,068 | 20,289 | D: show line 1 in the form |
| Open-market sales · 3,738 sh · avg $20.35 · $76,068 | |||||||
Loading xslF345X03/doc4.xml…